The Max Planck Florida Institute for Neuroscience (MPFI), a global leader in neural circuit research based in Jupiter, FL and Inscopix, Inc., a pioneering neurotechnology company based in Palo Alto, CA announced a new partnership to catalyze MPFI’s neural circuit research with Inscopix’s platform and capabilities for mapping brain circuit activity. Beyond empowering the researcher community at MPFI, these two organizations will support educational training for scientists in the broader neuroscience community, will provide key networking opportunities at research conferences, and will exchange ideas to facilitate the development of next-generation tools to drive groundbreaking discoveries.
In February 2019, MPFI will host the 4th annual Advanced Course in Neuroimaging Techniques, attracting international and domestic students to their Florida campus for hands-on training. Inscopix will lend both sponsorship and scientific expertise for training attendees on the latest tools and methods for monitoring and manipulating neural dynamics in freely behaving subjects. “We are excited to expand the scope of methods and offer this new training opportunity to the incredibly talented and eager minds that travel to our course, this approach is in great demand,” says Ryohei Yasuda, PhD, a co-director of the Institute and course. “Inscopix is enthusiastic to partner with MPFI to support its internal research programs and to help train a wider community of neuroscientists. This partnership will serve as a springboard to align Inscopix’s capabilities with MPFI’s broad research goals, sustaining their leadership in neuroscience research and together providing a rich scientific resource center for brain researchers,” says Inscopix’s founder and CEO Kunal Ghosh, PhD.
You can follow both organizations on Twitter to stay up-to-date on their activities (@MPFNeuro, @Inscopix).
About the Max Planck Florida Institute for Neuroscience
The Max Planck Florida Institute for Neuroscience (MPFI), a not-for-profit research organization, is part of the world-renowned Max Planck Society, Germany’s most successful research organization with over 80 institutes worldwide. Since its establishment in 1948, 18 Nobel laureates have emerged from the ranks of its scientists. As its first U.S. institution, MPFI brings together exceptional neuroscientists from around the world to answer fundamental questions about brain development and function and to develop new technologies that make groundbreaking scientific discoveries possible. Their research is shared publicly with scholars, universities and other organizations around the globe, providing the necessary foundation of knowledge to develop treatments and cures for brain disorders such as autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease. For more information, visit www.maxplanckflorida.org.
About Inscopix, Inc.
Inscopix is a discovery phase neuroscience company in Silicon Valley that is focused on advancing the mechanistic understanding of the brain at the level of neural circuits and networks. Inscopix develops miniaturized real-time brain mapping platforms that pave the way for incisive new insights into healthy brain function and for the development of next-generation treatments and therapeutics for brain disorders. Inscopix was recognized as a private-sector partner of the White House BRAIN Initiative in 2014, by the World Economic Forum as a Technology Pioneer in 2015, and by Deloitte’s Technology Fast 500 in 2016.